We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Vectura Group Plc | LSE:VEC | London | Ordinary Share | GB00BKM2MW97 | ORD 0.0271P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 164.80 | 164.80 | 165.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
01/2/2018 13:19 | I wonder how many big pharma execs have the FDA in their pocket. | celeritas | |
01/2/2018 13:03 | "How much was Advair going to add to the bottom line % wise??". Polaris normally has his spreadsheets primed ready to answer such questions! Paul? | popper joe | |
01/2/2018 12:46 | How much was Advair going to add to the bottom line % wise?? | pooroldboy55 | |
01/2/2018 12:27 | 6525 - I 'think' such a supposition is out of left universe rather than field matey!! All imho and meant playfully of course! | dunderheed | |
01/2/2018 12:21 | Key issue with Hikma is the fda view on the clinical endpoint study submitted as part of the ANDA.Statement due during Q1.If the fda insist on fresh clinical data rather than an issue of interpretation then we are in trouble! | fhmktg | |
01/2/2018 12:19 | thought out of left field: what if the major shareholder is selling out to help the company buy back its shares at a cheaper price? Sell out a partial clip to make the company look healthier to then reap the benefits on the rest of its holdings? | kolosos | |
01/2/2018 11:54 | Turning into a rout! | fhmktg | |
01/2/2018 11:24 | SoundBuy, spot on! The buy-back is helping the seller to exit at a better price. The buy-back should be halted temporarily and resumed when the seller has finished. | popper joe | |
01/2/2018 10:56 | Didn't expect to get back in at this price but here I am :)Chart support around this price, over reaction to Amazon's plans to enter the US market to drive down health care costs. Should see this bounce off 106ish... fingers crossed. | rathean | |
01/2/2018 10:41 | The buy back provides the liquidity......if they have a time frame to exit then take advantage...... (sitting on hands.....still..... | soundbuy | |
01/2/2018 10:38 | Company imo unwise spent shareholders money for buy back / helping sellers . Ceo is incompetent to run this company and cfo sold at 145 p What can we expect ? Probably undervalued now , but sentiment is broken . Major shareholders should take company private at this price. And sell then products to major Pharma cos. Anybody knows what worth Vectura without Advair ? | a1ord53 | |
01/2/2018 10:36 | As i see it the seller wants out PDQ ,with the buy back could have been done more slowly , | pooroldboy55 | |
01/2/2018 10:31 | I have. Lunacy | richtea2517 | |
01/2/2018 10:30 | ......but a tad tempting eh.......grrrrrr | soundbuy | |
01/2/2018 10:29 | Was tempted to re-enter at just over 91p there...........but that'd just be me looking at the chart.........somebo | soundbuy | |
01/2/2018 10:10 | Anyone know this... If a major shareholder is selling, say 5mill shares, how long can this be worked before reporting? There have been no major holders reporting for a while, so is this just being traded lower, I don't see any recent news that should have reversed the recent trend so sharply. | diesel | |
01/2/2018 09:43 | Have been thinking the same thing what are we down nearly 20% in 3 days. | pooroldboy55 | |
01/2/2018 09:40 | Hard to believe the CEO isn't aware of a reason or not privy to something which would explain the share price drop and fails to inform the market as he should. | cumnor | |
01/2/2018 08:48 | Lucky boy!I'm bleeding like a stuck pig!£1.30 is a long way to go. | fhmktg | |
01/2/2018 08:46 | Well this is some sell off as I said the other day can en us in the 80s before long like everyone on this board haven't got a clue what's going on .74p my break even so some way to go ,getting a bit like the old SKP days. | pooroldboy55 | |
01/2/2018 07:28 | Hbm were increasing there stake in SKP at 30p 50p 70p and fully took up in all the late fundraising. So selling vectura even at 80p they will be making a profit it could be even lower than that. | best1467 | |
01/2/2018 07:19 | Another 800000 shares bought-back yesterday and the share price tanks again. If, as has been suggested, this has been timed to coincide with HBM bailing out, with the intent of supporting the share price during their sell-off, it doesn't appear to be working. Or perhaps it is! But I would now have think that the best approach would be to temporarily cease buying and let HBM suffer whatever loss they are prepared to take. The buy-back can then resume at bargain levels and have a far greater effect on earnings per share if that is the true aim of the buy-back. | popper joe |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions